(Reference: Wilding et al., NEJM, 2021) Staying on GLP-1 medication is not forever is not necessary
Liraglutide (Saxenda) At the highest recommended dose of 3 mg, Liraglutide lowers blood pressure an average of 3.2 mmHg, with no apparent effect on diastolic blood pressure
Ipamorelin (5mg): A selective growth hormonereleasing peptide (GHRP) that mimics the action of ghrelin on the ghrelin receptor, promoting GH release without significant effects on appetite or cortisol
There are three injection strategies that control the risks of freckles
Alcohol and smoking deplete glutathione levels and reduce supplement effectiveness
Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial